SGLT2 inhibition with empagliflozin attenuates retinal oxidative stress and damage in diabetic mice
Yutong Xia, Jiru Zhu, Xin Yu, Zhitong Chen et autres
To investigate the effects of empagliflozin (EMPA), an SGLT2 inhibitor, on retinal damage in diabetic mice, exploring its potential as a therapeutic strategy for diabetic retinopathy (DR). DR was induced by a high-fat diet and streptozotocin injections, followed by EMPA treatment. The …
cn (code pays fourni par la source)